Water Logos

lp-banner-blue-3d-dna-helix.jpg

Be the First to Learn About Cutting-Edge Analytical Technology

Access a copy of our presentation from ASGCT today!

Recently, Waters shared the latest innovations in gene therapy analytical technology with the scientific community at ASGCT 2025. Waters and our Lexeo collaborators led a scientific presentation sharing:

  • Advancements in the characterization of megadalton biologics: Essential for cell and gene therapies, tools like size-exclusion chromatography (SEC) for high-resolution analysis improve resolution and reduce non-specific interactions.
  • Innovative analytical techniques: Combining SEC with multi-angle light scattering (MALS) and charge detection mass spectrometry (CDMS) provides deeper insights into molecular attributes and rapid, precise characterization of biologics.
  • Case studies and applications: Examples were shared, like analysis of Cominarty, Spikevax, mRNA drug substances, lentiviral vectors, and AAV purity investigations, highlighting the practical applications of these advanced techniques.

Sponsored Symposia - Breakthroughs in Gene Therapy Analytics: Potency and Purity-Indicating Assays Using Advanced Size Exclusion Chromatography (SEC) and Charge Detection Mass Spectrometry (CDMS)

Matthew Lauber, Senior Director of Bioseparations, Waters
Noah Miller-Medzon, Downstream Process Development Lead, Lexeo Therapeutics

This talk covered the characterization of megadalton-sized biologics, such as lipid nanoparticle mRNA, plasmids, capsids, and viral vectors, which are vital for cell and gene therapy development and testing. SEC is highlighted as a key method for separating these complex modalities, with innovations in SEC column technology enhancing resolution and reducing non-specific interactions. CDMS, particularly in compact benchtop systems, provides rapid and precise characterization of biologics, including detailed analysis of AAV vectors.